In recent years, there has been growing interest in liquified natural gas (LNG) as a potential clean energy alternative by all parties with interest in the decarbonisation trend. This includes energy companies, investors, governments and even the broader public.
LNG has pros and cons
With concerns about climate change and the need to reduce greenhouse gas…
If you've looked at the list of ASX 200 companies in the past few days, you'll see a company called Dyno Nobel and see Incitec Pivot gone. That is because Incitec changed its name, effective from the commencement of trade last Wednesday (April 2) following shareholder approval at last November's AGM.
Many who aren't familiar with…
Orthocell (ASX:OCC) is the latest ASX biotech to obtain FDA approval. Its nerve repair product Remplir was already approved in Australia, New Zealand and Singapore, plus approval is pending in Canada and Thailand. But the US was the biggest piece of the US$3.5bn pie that is the company's global addressable market, and now it is…
Many would be wondering how tariffs impact the stock market and its investors. On 'Liberation Day', the returned President Trump imposed tariffs well beyond even what he imposed during his first time, or any US President has imposed in living memory (at least in the enmasse manner he did so - imposing them on friends…
In this article, we look at 5 of the oldest companies on the ASX.
Now, we are not claiming these companies to be the oldest because this is up for debate. Several companies that may appear young can trace their origins back many decades prior, whilst others that may appear old are different businesses to what…
Trump Tariffs: They're back with a vengeance and even worse than last time. During the first Trump administration, tariffs were mostly only imposed on China, but they're back with a vengeance.
On so-called Liberation Day, the administration revealed reciprocal tariffs on just about all countries. Australia is not exempt although it has escaped with a 10%…
Ramelius Resources' (ASX:RMS) $3bn market cap may suggest it is expensive, but its P/E (7x for FY25 and 10.9x for FY26) would suggest it is cheap. What's the story?
Ramelius Resources is one of the few aspirants to have made it
20 years ago, Ramelius was another small cap explorer with dreams of making it as…
If you own shares in a delisted ASX company, you're probably wondering what to do. Some stocks have a happy ending in being taken over at a healthy premium, but some end up going bankrupt and leaving shareholders having lost all their money.
But it may not be the end of everything for investors even after…
As Artificial Intelligence (AI) becomes more widespread, investors are asking how to use AI to pick stocks. We will cover how you can, but also whether or not you really should be using it.
There's no one size fits all answer, it all depends on your risk tolerance, goals, and your understanding of the specific AI…
There are few ASX shares that have seen such a fall from grace as Appen shares since 2020. In those days, Appen was such a good stock, it was part of a quintet of stocks deemed the WAAAX stocks and claimed to have outperformed the American FAANG stocks. Moreover, it was capitalised at over $3bn.
While…
